Concept and Potential of Enteric Dialysis® - Treating the Cause of Dysbiosis and not the Symptoms in Chronic Kidney Diseases (CKD)
Year: 2015
Type: article
Abstract: Since our first review article on this subject matter, several other reviews have been published as of now [1][2][3][4][5][6][7][8][9].All of these independent reviews in various scientific journals reflect on various topics such as gut Microbiome, its dysbiosis, impact of the altered intestinal characteristics including small bowel bacterial overgrowth, newer uremic toxins, adsorbent drugs and several observational small scale clinical studies from Kibow [10-14] and a host of others (all of these are referenced in the review articles).This commentary is mainly written to connect various aspects of scientific understanding with greater emphasis on the health economics and potential of probiotics and prebiotics towards CKD applications both in developed and developing countries.Hence, with all humility, the author has undertaken to revisit and review the subject matter and thus help offer his independent views in connecting the failing KIdney function by the BOWel as was originally conceived by the distinguished thought leader of Renal Sciences -Dr Eli A Friedman [15,16].Out of this concept was born "KIBOW" in the year 1997 and the concept is now being more scientifically researched, commercially validated and realized as "Gut and Kidney connection".
Author: Natarajan Ranganathan
Institution: Kibow Biotech (United States)
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W2597030963
